Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Empagliflozin high
DRUG
2 trials
Sponsors
Boehringer Ingelheim
, Handok Inc.
Conditions
Diabetes Mellitus, Type 1
Healthy Volunteers
Phase 1
Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
Completed
NCT06889350
Handok Inc.
Healthy Volunteers
Start: 2025-03-26
End: 2025-05-07
Updated: 2025-07-31
Phase 2
Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days
Completed
NCT01969747
Boehringer Ingelheim
Diabetes Mellitus, Type 1
Start: 2013-11-30
End: 2014-04-30
Updated: 2015-04-08
Related Papers
Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1).
2016-12-08
39 citations